Effect of the protease inhibitor MG132 on the transforming growth factor-β/Smad signaling pathway in HSC-T6 cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 4, 2013, Pages 501-504

  Ren, Zhang Peng ^a,b   Sun, Li Ping ^a   Xia, You Chen ^a   Tong, Qiao Xia ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Xinxiang Center Hospital   (China)

Author keywords

HSC T6; liver fibrosis; MG132; TGF Smad pathway

Indexed keywords

BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; LEUPEPTIN; PROTEINASE INHIBITOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CELL LINE; DRUG EFFECT; METABOLISM; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; LEUPEPTINS; PROTEASE INHIBITORS; RATS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84881284419     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1149-0     Document Type: Article

References (20)

1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology, 2008,134(6): 1655-1669
2. Friedman SL. Hepatic fibrosis-overview. Toxicology, 2008,254(3):120-129
3. Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology, 2002,122(5):1525-1528
4. Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest, 1998,102(3): 538-549
5. Iredale JP. Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis, 2001,21(3):427-436
6. Kavsak P, Rasmussen RK, Causing CG, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell, 2000,6(6):1365-1375
7. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet, 2008,371(9615):838-851
8. Kisseleva T, Brenner DA. Mechanisms of fibrogenesis. Exp Biol Med, 2008,233(2):109-122
9. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol, 2004,85(2):47-64
10. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 2001,29(9):e45
11. Wang C, Kim T, Gao D, et al. Rapid high-yield mRNA extraction for reverse-transcription PCR. J Biochem Biophys Methods, 2007,70(3):507-509
12. Kaimori A, Potter J, Kaimori JY, et al. Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem, 2007,282(30):22089-22101
13. Inagaki Y, Okazaki I. Emerging insights into transforming growth factor-β/Smad signal in hepatic fibrogenesis. Gut, 2007,56(2):284-292
14. Dooley S, Ten Dijke P. TGF-β in progression of liver disease. Cell Tissue Res, 2012,347(1):245-256
15. Uemura M, Swenson ES, Gaca MD, et al. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and α-smooth muscle actin organization. Mol Biol Cell, 2005,16(9):4214-4224
16. Wang J, Maldonado MA. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol, 2006,3(4):255-261
17. Liu X, Wen FQ, Kobayashi T, et al. Smad3 mediates the TGF-beta-induced contraction of type I collagen gels by mouse embryo fibroblasts. Cell Motil Cytoskeleton, 2003,54(3):248-253
18. Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology, 2003,125(1):178-191
19. Zhang F, Laiho M. On and off: proteasome and TGF-beta signaling. Exp Cell Res, 2003,291(2):275-281
20. Schnabl B, Kweon YO, Frederick JP, et al. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology, 2001,34(1):89-100